With rapid innovations in biotechnology, companies are developing improved therapies and diagnostic tools addressing chronic diseases and improving patient outcomes. Moreover, the inclusion of modern tools like artificial intelligence and robotics are also contributing towards shifting gears for the biotech industry.
Amid this backdrop, investing in fundamentally stable biotech stocks, Vertex Pharmaceuticals Incorporated (VRTX), Amgen Inc. (AMGN), and Gilead Sciences, Inc. (GILD) could be the move for investors looking to capitalize on the sector’s expansion.
